## Abstract The optimal source of stem cells for regenerative medicine is a major question. Embryonic stem (ES) cells have shown promise for pluripotency but have ethical issues and potential to form teratomas. Pluripotent stem cells have been produced from skin cells by either viralβ, plasmidβ or
Pluripotency: Toward a gold standard for human ES and iPS cells
β Scribed by Kelly P. Smith; Mai X. Luong; Gary S. Stein
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 219 KB
- Volume
- 220
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
With the advent of technologies for the derivation of embryonic stem cells and reprogrammed stem cells, use of the term βpluripotentβ has become widespread. Despite its increased scientific and political importance, there are ambiguities with this designation and a common standard for experimental approaches that precisely define this state in human cells remains elusive. Recent studies have revealed that reprogramming may occur via many pathways which do not always lead to pluripotency. In addition, the pluripotent state itself appears to be highly dynamic, leading to significant variability in the results of molecular studies. Establishment of a stringent set of criteria for defining pluripotency will be vital for biological studies and potential clinical applications in this rapidly evolving field. In this review, we explore the various definitions of pluripotency, examine the current status of pluripotency testing in the field and provide an analysis of how these assays have been used to establish pluripotency in the scientific literature. J. Cell. Physiol. 220: 21β29, 2009. Β© 2009 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract Cell therapy using human embryonic stem cells (hESCs) is a promising therapeutic option for Parkinson's disease (PD), an incurable neurodegenerative disease. A prerequisite for clinical application of hESCs for PD is an efficient and strict differentiation of hESCs into midbrain dopamin